Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Ylenia Ingrasciotta"'
Autor:
Ylenia Ingrasciotta, Andrea Spini, Luca L'Abbate, Elena Sofia Fiore, Massimo Carollo, Valentina Ientile, Valentina Isgrò, Anna Cavazzana, Valeria Biasi, Paola Rossi, Lucian Ejlli, Valeria Belleudi, Francesca Poggi, Ester Sapigni, Aurora Puccini, Domenica Ancona, Paolo Stella, Sebastiano Pollina Addario, Alessandra Allotta, Olivia Leoni, Martina Zanforlini, Marco Tuccori, Rosa Gini, Gianluca Trifirò
Publikováno v:
Pharmacological Research, Vol 200, Iss , Pp 107074- (2024)
To date, no population-based studies have specifically explored the external validity of pivotal randomized clinical trials (RCTs) of biologics simultaneously for a broad spectrum of immuno-mediated inflammatory diseases (IMIDs). The aims of this stu
Externí odkaz:
https://doaj.org/article/fbf32f8cdfda43e9a16612d9bd69cfa3
Autor:
Carlos E. Durán, Judit Riera-Arnau, Shahab Abtahi, Romin Pajouheshnia, Vjola Hoxhaj, Magdalena Gamba, Ema Alsina, Mar Martin-Perez, Patricia Garcia-Poza, Ana Llorente-Garcia, Diana Gonzalez-Bermejo, Luisa Ibánez, Mònica Sabaté, Xavier Vidal, Elena Ballarín, Gabriel Sanfélix-Gimeno, Clara Rodríguez-Bernal, Salvador Peiró, Aníbal García-Sempere, Francisco Sanchez-Saez, Valentina Ientile, Ylenia Ingrasciotta, Claudio Guarneri, Matilde Tanaglia, Michele Tari, Ron Herings, Eline Houben, Karin Swart-Polinder, Emily Holthuis, Consuelo Huerta, Rosa Gini, Giuseppe Roberto, Claudia Bartolini, Olga Paoletti, Giorgio Limoncella, Anna Girardi, Giulia Hyeraci, Morten Andersen, Sarah Brøgger Kristiansen, Christine Erikstrup Hallgreen, Olaf Klungel, Miriam Sturkenboom
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: In March 2018, the European pregnancy prevention programme for oral retinoids was updated as part of risk minimisation measures (RMM), emphasising their contraindication in pregnant women.Objective: To measure the impact of the 2018 revis
Externí odkaz:
https://doaj.org/article/97c75f28f2b14a79838ac1ce448b894e
Autor:
Laura Macca, Federica Li Pomi, Ylenia Ingrasciotta, Pietro Morrone, Gianluca Trifirò, Claudio Guarneri
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Psoriasis and hidradenitis suppurativa are chronic inflammatory skin diseases that can develop together, negatively impacting on the patient’s quality of life. We aimed to review the most up-to-date information regarding the epidemiology, pathogene
Externí odkaz:
https://doaj.org/article/25793a0d9f984348899d86f7cfec4f42
Autor:
Vito Di Lernia, Laura Macca, Lucia Peterle, Ylenia Ingrasciotta, Gianluca Trifirò, Claudio Guarneri
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Psoriasis is a chronic, immune-mediated skin disease that may occur at any age. Prevalence in children ranges between 0.5 and 1.0% across Europe. Approximately 10–20% of paediatric psoriasis patients are moderate-to-severe in severity a
Externí odkaz:
https://doaj.org/article/1e90a780d1714986a5e3ff54f738bd0a
Autor:
Laura Macca, Vittoria Moscatt, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2761 (2022)
Hidradenitis suppurativa (HS) is a chronic, debilitating skin disease of the apocrine glands. Bibliographic search revealed few studies concerning the association between HS and human immunodeficiency virus (HIV). To assess this link, we performed a
Externí odkaz:
https://doaj.org/article/6085aa17dc134829aaabdbe6ac955b0d
Autor:
Laura Macca, Lucia Peterle, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1647 (2022)
Several cutaneous manifestations in patients undergoing COVID-19 vaccination have been described in the literature. Herein, we presented a case of new-onset vitiligo that occurred after the second dose of the Comirnaty vaccine. An updated literature
Externí odkaz:
https://doaj.org/article/510bb54825bd4a00be4cda629675be60
Autor:
Salvatore Crisafulli, Lucrezia Bertino, Andrea Fontana, Fabrizio Calapai, Ylenia Ingrasciotta, Massimiliano Berretta, Gianluca Trifirò, Claudio Guarneri
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Cancer is one of the several comorbidities that have been linked with chronic cutaneous inflammatory diseases namely psoriasis/psoriatic arthritis and hidradenitis suppurativa. Although the chronic inflammatory state, typical of the diseases, may ind
Externí odkaz:
https://doaj.org/article/99fce050d3ae455d857104f7fbf8039d
Autor:
Ylenia Ingrasciotta, Viviana Lacava, Ilaria Marcianò, Francesco Giorgianni, Giovanni Tripepi, Graziella D’ Arrigo, Alessandro Chinellato, Daniele Ugo Tari, Domenico Santoro, Gianluca Trifirò
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Evidences show that around 20% of biosimilar or originator erythropoiesis-stimulating agents (ESAs) users are hyporesponsive. Controversial post-marketing data exist on the predictors of ESA hyporesponsiveness. The aim of this stu
Externí odkaz:
https://doaj.org/article/08381c8e2b2f41c8ad8b4e5225aa1f8b
Autor:
Katja A. Oppelt, Josephina G. Kuiper, Ylenia Ingrasciotta, Valentina Ientile, Ron M. C. Herings, Michele Tari, Gianluca Trifirò, Ulrike Haug
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Introduction: Biologics were approved for the treatment of advanced colorectal cancer (CRC) based on favorable benefit-risk-assessments from randomized controlled trials (RCTs), but evidence on their use in the real-world setting is scarce. Based on
Externí odkaz:
https://doaj.org/article/9d14946394834ea08de389b1eabf0e07
Autor:
Alfonso Motolese, Manuela Ceccarelli, Laura Macca, Federica Li Pomi, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 228 (2022)
Psoriasis is a chronic immune-mediated skin and joint disease, with a plethora of comorbidities, characterized by a certain genetic predisposition, and a complex pathogenesis based on the IL-23/IL-17 pathway. There is no doubt that the patients affec
Externí odkaz:
https://doaj.org/article/e11679e3fb294b7ba7a788926bdb0d70